| Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry A Aghamohammadi, P Mohammadinejad, H Abolhassani, B Mirminachi, ... Journal of clinical immunology 34, 478-490, 2014 | 157 | 2014 |
| Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ... Bipolar disorders 17 (6), 606-614, 2015 | 104 | 2015 |
| Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial H Emadi-Kouchak, P Mohammadinejad, A Asadollahi-Amin, ... International clinical psychopharmacology 31 (1), 20-26, 2016 | 89 | 2016 |
| Autoimmune phenotype in patients with common variable immunodeficiency H Abolhassani, D Amirkashani, N Parvaneh, P Mohammadinejad, ... J Investig Allergol Clin Immunol 23 (5), 323-9, 2013 | 81 | 2013 |
| CT noise-reduction methods for lower-dose scanning: strengths and weaknesses of iterative reconstruction algorithms and new techniques P Mohammadinejad, A Mileto, L Yu, S Leng, LS Guimaraes, AD Missert, ... Radiographics 41 (5), 1493-1508, 2021 | 78 | 2021 |
| Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial M Shalbafan, P Mohammadinejad, SV Shariat, K Alavi, A Zeinoddini, ... Pharmacopsychiatry 48 (04/05), 136-140, 2015 | 73 | 2015 |
| Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial SH Abbasi, P Mohammadinejad, N Shahmansouri, A Salehiomran, ... Journal of Affective Disorders 183, 149-155, 2015 | 69 | 2015 |
| Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ... Psychiatry and Clinical Neurosciences 70 (8), 332-341, 2016 | 64 | 2016 |
| Carotid artery corrected flow time measurement via bedside ultrasonography in monitoring volume status H Hossein-Nejad, P Mohammadinejad, M Lessan-Pezeshki, SS Davarani, ... Journal of critical care 30 (6), 1199-1203, 2015 | 64 | 2015 |
| The difference between computed tomography and magnetic resonance imaging measurements of tibial tubercle–trochlear groove distance for patients with or without patellofemoral … SHS Tan, BY Lim, KSJ Chng, C Doshi, FKL Wong, AKS Lim, JH Hui The Journal of Knee Surgery 33 (08), 768-776, 2020 | 57 | 2020 |
| Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ... Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016 | 56 | 2016 |
| Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial E Salardini, A Zeinoddini, P Mohammadinejad, MR Khodaie-Ardakani, ... Journal of psychiatric research 75, 24-30, 2016 | 55 | 2016 |
| 8 Pediatric Patients With Common Variable Immunodeficiency: Long-term Follow-up P Mohammadinejad, A Aghamohammadi, H Abolhassani, MS Sadaghiani, ... Journal of Investigational Allergology and Clinical Immunology 22 (3), 208, 2012 | 52 | 2012 |
| The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016 | 50 | 2016 |
| Celecoxib versus diclofenac in mild to moderate depression management among breast cancer patients: A double-blind, placebo-controlled, randomized trial P Mohammadinejad, P Arya, M Esfandbod, A Kaviani, M Najafi, L Kashani, ... Annals of Pharmacotherapy 49 (9), 953-961, 2015 | 50 | 2015 |
| Primary antibody deficiency in a tertiary referral hospital: a 30-year experiment. P Mohammadinejad, S Pourhamdi, H Abolhassani, B Mirminachi, ... Journal of investigational allergology & clinical immunology 25 (6), 416-425, 2015 | 49 | 2015 |
| The approach to children with recurrent infections A Aghamohammadi, H Abolhassani, P Mohammadinejad, N Rezaei Iranian Journal of Allergy, Asthma and Immunology 11 (2), 89, 2012 | 44 | 2012 |
| A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania SY Mousavi, R Khezri, MA Karkhaneh-Yousefi, P Mohammadinejad, ... Journal of Child and Adolescent Psychopharmacology 27 (6), 494-500, 2017 | 41 | 2017 |
| Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study M Amidfar, M Khiabany, A Kohi, E Salardini, M Arbabi, M Roohi Azizi, ... Journal of clinical pharmacy and therapeutics 42 (1), 44-50, 2017 | 41 | 2017 |
| Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis A Aghamohammadi, ZG Moghaddam, H Abolhassani, Z Hallaji, ... Allergologia et immunopathologia 42 (4), 336-341, 2014 | 41 | 2014 |
